The FDA has sent a warning letter to a company charging that its adipose-derived stem cell treatments -- known as stromal ...

Capricor Therapeutics (NASDAQ: CAPR) has announced the initiation of the rolling submission process with the U.S. Food and ...

The deal allows MSD to license one or more therapies against inflammatory diseases developed using the UK biotech’s ...

The adaptation of immune cells to their local microenvironments in our body is central to tissue homeostasis and linked to ...

This valuable study reports on a novel role of PD-1 in early T cell differentiation, showing that PD-1 stimulation impairs Th2 differentiation more effectively than that of Th1, with implications for ...

Mestag Therapeutics has been working to change how fibroblasts are activated and how they expand. Now, Merck & Co. | Mestag ...

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- (MiNK, NASDAQ: INKT) a clinical-stage company pioneering the development of allogeneic off-the-shelf, invariant natural killer T (iNKT) cell therapies and ...

(Induced pluripotent stem cells, or iPSCs, are capable of differentiating into any cell type in the body.) Similarly, they’ve ...

A cross-disciplinary team, led by the University of Glasgow, alongside the Universities of Nottingham and Strathclyde, will use pioneering technology ...

A cross-disciplinary team, led by the University of Glasgow, will use pioneering technology to manufacture human stem cells ...

The decision, experts say, reasserts the FDA’s authority over regenerative medicine at a time when clinics advertising these ...